News

An iPhone Knows Your Significant Locations - Keep in mind that iPhones use a particular method to track the smartphone’s ...
In a blog post, Microsoft announced that anyone with the Microsoft Bing Search mobile app can now generate their own AI videos—for free. The new feature is powered by Sora, OpenAI’s top-of-the-line ...
Create professional presentations in minutes with Manus Slides. Save time, customize easily, and deliver impactful ideas ...
Apple Music could get more visual flair in iOS 26 with full-screen animated artwork coming to the Lock Screen, according to ...
YANTAI, China, June 2, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ... combined with CAPOX or trastuzumab as the first-line therapy for HER2-expressing ...
YANTAI, China, June 2, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO Annual Meeting, Dr. Lin Shen from Beijing Cancer Hospital presented the results of a ...
At this year's ASCO meeting, IBI363 reported encouraging Phase 1/2 clinical data in the first three indications explored—non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and melanoma ...
About IBI363 (First-in-class PD-1/IL-2α-bias bispecific antibody fusion protein) IBI363 is a first-in-class PD-1/IL-2α-bias bispecific antibody fusion protein independently developed by Innovent ...
ORR: 71.4% vs 66.7% vs 56.3%; 6-month PFS rate: 71.4%,72.7% and 53.3%. Globally, this is the first study to explore the triple combination therapy of "HER2 ADC + PD-1 + targeted medication" as ...